The Microvascular Function of GLP-1 and Its Analogues

NCT01677104 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Obesity

Interventions

DRUG: GLP-1
DRUG: Placebo

Sponsor

Katarina Kos

Collaborators

[object Object]